Mileshkin L - Search Results

1

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.

de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D'Amico R, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Gribaudo S, Provencher D, Hanzen C, Kruitwagen RF, Smit VTHBM, Singh N, Do V, Lissoni A, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC Study Group. de Boer SM, et al. Among authors: mileshkin l. Lancet Oncol. 2019 Sep;20(9):1273-1285. doi: 10.1016/S1470-2045(19)30395-X. Epub 2019 Jul 22. Lancet Oncol. 2019. PMID: 31345626 Free PMC article. Clinical Trial.

2

Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer.

Rischin D, Narayan K, Oza AM, Mileshkin L, Bernshaw D, Choi J, Hicks R, McClure B, Fyles A. Rischin D, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2010 Jul;20(5):827-33. doi: 10.1111/IGC.0b013e3181dc827e. Int J Gynecol Cancer. 2010. PMID: 20606530 Free article. Clinical Trial.

3

Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.

Obermair A, Mileshkin L, Bolz K, Kondalsamy-Chennakesavan S, Cheuk R, Vasey P, Wyld D, Goh J, Nicklin JL, Perrin LC, Sykes P, Janda M. Obermair A, et al. Among authors: mileshkin l. Gynecol Oncol. 2011 Feb;120(2):179-84. doi: 10.1016/j.ygyno.2010.10.039. Epub 2010 Dec 3. Gynecol Oncol. 2011. PMID: 21126755 Clinical Trial.

4

Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.

Narayan K, Khaw P, Bernshaw D, Mileshkin L, Kondalsamy-Chennakesavan S. Narayan K, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2012 Feb;22(2):260-6. doi: 10.1097/IGC.0b013e318230c264. Int J Gynecol Cancer. 2012. PMID: 22080878 Free article.

5

Radiation with cisplatin or carboplatin for locally advanced cervix cancer: the experience of a tertiary cancer centre.

Au-Yeung G, Mileshkin L, Bernshaw DM, Kondalsamy-Chennakesavan S, Rischin D, Narayan K. Au-Yeung G, et al. Among authors: mileshkin l. J Med Imaging Radiat Oncol. 2013 Feb;57(1):97-104. doi: 10.1111/j.1754-9485.2012.02463.x. Epub 2012 Oct 18. J Med Imaging Radiat Oncol. 2013. PMID: 23374561

6

Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.

Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J, O'Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian Cancer Patterns of Care Study Group. Jordan S, et al. Gynecol Oncol. 2013 May;129(2):310-7. doi: 10.1016/j.ygyno.2013.02.007. Epub 2013 Feb 9. Gynecol Oncol. 2013. PMID: 23403164 Free article.

7

Oral cyclophosphamide in recurrent ovarian cancer.

Handolias D, Quinn M, Foo S, Mileshkin L, Grant P, Dutu G, Rischin D. Handolias D, et al. Among authors: mileshkin l. Asia Pac J Clin Oncol. 2016 Mar;12(1):e154-60. doi: 10.1111/ajco.12074. Epub 2013 May 29. Asia Pac J Clin Oncol. 2016. PMID: 23718870

8

Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.

Paramanathan A, Solomon B, Collins M, Franco M, Kofoed S, Francis H, Ball D, Mileshkin L. Paramanathan A, et al. Among authors: mileshkin l. Clin Lung Cancer. 2013 Sep;14(5):508-12. doi: 10.1016/j.cllc.2013.03.007. Epub 2013 Jun 20. Clin Lung Cancer. 2013. PMID: 23792009

9

Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).

Au-Yeung G, Webb PM, DeFazio A, Fereday S, Bressel M, Mileshkin L. Au-Yeung G, et al. Among authors: mileshkin l. Gynecol Oncol. 2014 Apr;133(1):16-22. doi: 10.1016/j.ygyno.2014.01.030. Gynecol Oncol. 2014. PMID: 24680586

10

Smokers with cervix cancer have more uterine corpus invasive disease and an increased risk of recurrence after treatment with chemoradiation.

Mileshkin L, Paramanathan A, Kondalsamy-Chennakesavan S, Bernshaw D, Khaw P, Narayan K. Mileshkin L, et al. Int J Gynecol Cancer. 2014 Sep;24(7):1286-91. doi: 10.1097/IGC.0000000000000170. Int J Gynecol Cancer. 2014. PMID: 24987916 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters